NCT00457665View on ClinicalTrials.gov

Mechanisms of Lipodystrophy in HIV-Infected Pateints

PHASE4CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2014

Conditions
HIV Infections
Interventions
DRUG

Nelfinavir

DRUG

Efavirenz

Trial Locations (1)

75390

University of Texas Southwestern Medical Center, Dallas

Sponsors
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Texas Southwestern Medical Center

OTHER

NCT00457665 - Mechanisms of Lipodystrophy in HIV-Infected Pateints | Biotech Hunter | Biotech Hunter